PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
PRO DEX INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 3, 2026
$57.70−0.56 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $193.98M
- P/E (TTM)
- 14.0
- Dividend yield
- –
Pro Dex statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Pro Dex | Industry median |
|---|---|---|
| Market Cap | $184.83M | $230.55M |
| Enterprise Value | $188.76M | $202.97M |
| PE Ratio | 14.00 | 33.40 |
| PS Ratio | 2.38 | 3.11 |
| PB Ratio | 3.88 | 3.14 |
| P/TBV Ratio | 4.57 | 4.57 |
| P/FCF Ratio | 27.35 | 27.25 |
| P/OCF Ratio | 25.52 | 22.35 |
Enterprise value
| Measure | Pro Dex | Industry median |
|---|---|---|
| EV / Sales | 2.43 | 2.92 |
| EV / EBITDA | 13.12 | 19.86 |
| EV / EBIT | 14.53 | 24.88 |
| EV / FCF | 27.93 | 27.85 |
Income (trailing twelve months)
| Measure | Pro Dex | Industry median |
|---|---|---|
| Revenue | $77.55M | $102.39M |
| Gross Profit | $24.34M | $60.36M |
| Operating Income | $12.99M | -$4.31M |
| Pretax Income | $18.02M | -$2.26M |
| Net Income | $13.66M | -$6.57M |
| EBITDA | $14.39M | -$1.98M |
| EPS (Diluted) | $4.12 | -$0.07 |
Margins
| Measure | Pro Dex | Industry median |
|---|---|---|
| Gross Margin | 31.4% | 55.1% |
| Operating Margin | 16.8% | -6.04% |
| Pretax Margin | 23.2% | -4.11% |
| Profit Margin | 17.6% | -10.5% |
| EBITDA Margin | 18.5% | -2.67% |
| FCF Margin | 8.72% | -0.30% |
Returns
| Measure | Pro Dex | Industry median |
|---|---|---|
| Return on Equity (ROE) | 32.4% | -19.2% |
| Return on Assets (ROA) | 20.1% | -13.3% |
| Return on Invested Capital (ROIC) | 21.8% | -4.11% |
| Return on Capital Employed (ROCE) | 21.1% | -9.07% |
Growth
| Measure | Pro Dex | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 16.5% | 8.85% |
| Net Income Growth (YoY) | 52.2% | 10.6% |
| EPS Growth (YoY) | 54.3% | 10.6% |
| Revenue Growth (3Y CAGR) | 18.9% | 7.08% |
| Revenue Growth (5Y CAGR) | 15.3% | 11.8% |
| EPS Growth (3Y CAGR) | 28.3% | 3.06% |
| EPS Growth (5Y CAGR) | 21.3% | 7.64% |
Balance sheet
| Measure | Pro Dex | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.34M | $37.33M |
| Total Debt | $13.27M | $72.66M |
| Net Cash (Debt) | -$3.92M | $3.92M |
| Net Cash Per Share | -$1.22 | $0.28 |
| Equity (Book Value) | $47.63M | $57.36M |
| Book Value Per Share | $14.87 | $2.81 |
| Tangible Book Value | $40.42M | $10.71M |
| Working Capital | $40.27M | $54.64M |
Financial position
| Measure | Pro Dex | Industry median |
|---|---|---|
| Current Ratio | 4.10 | 2.50 |
| Quick Ratio | 2.35 | 1.54 |
| Debt / Equity | 0.28 | 0.38 |
| Debt / EBITDA | 0.92 | 2.31 |
| Debt / FCF | 1.96 | 3.50 |
| Net Debt / EBITDA | 0.27 | 1.53 |
| Interest Coverage | 16.00 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Pro Dex | Industry median |
|---|---|---|
| Operating Cash Flow | $7.24M | -$653.46K |
| Capital Expenditures | -$483.00K | -$3.69M |
| Free Cash Flow | $6.76M | -$835.02K |
| FCF Per Share | $2.11 | -$0.02 |
Efficiency
| Measure | Pro Dex | Industry median |
|---|---|---|
| Asset Turnover | 1.14 | 0.59 |
| Inventory Turnover | 2.44 | 2.21 |
| Revenue Per Employee | $428.44K | $322.57K |
| Profits Per Employee | $75.48K | -$51.88K |
| Employee Count | 181 | 185 |
Dividends and yields
| Measure | Pro Dex | Industry median |
|---|---|---|
| Earnings Yield | 7.39% | -6.91% |
| FCF Yield | 3.66% | -0.56% |
| Buyback Yield | 1.84% | 0.78% |
| Shareholder Yield | 1.84% | 0.80% |
Shares
| Measure | Pro Dex | Industry median |
|---|---|---|
| Shares Outstanding | 3,203,330 | 44,856,700 |
| Shares Change (YoY) | -1.31% | 3.35% |
| Shares Change (QoQ) | -0.33% | 0.27% |
| Float | 1,740,840 | 37,097,900 |
| Shares Held by Insiders | 45.7% | 10.6% |
| Shares Held by Institutions | 22.9% | 63.5% |
Taxes
| Measure | Pro Dex | Industry median |
|---|---|---|
| Income Tax | $4.35M | $1.52M |
| Effective Tax Rate | 24.2% | 18.6% |
Scores
| Measure | Pro Dex | Industry median |
|---|---|---|
| Graham Number | $37.13 | $34.37 |
| Graham Upside | -35.7% | -57.7% |
| Altman Z-Score | 7.29 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.56 | -2.64 |
Calculated by StockData from Pro Dex's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.